Correlation Between Dynavax Technologies and Allogene Therapeutics

Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and Allogene Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and Allogene Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dynavax Technologies and Allogene Therapeutics, you can compare the effects of market volatilities on Dynavax Technologies and Allogene Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of Allogene Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and Allogene Therapeutics.

Diversification Opportunities for Dynavax Technologies and Allogene Therapeutics

-0.52

Correlation Coefficient

Dynavax Technologies  Allogene Therapeutics

Excellent diversification

The 3 months correlation between Dynavax and Allogene is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and Allogene Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allogene Therapeutics and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with Allogene Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allogene Therapeutics has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and Allogene Therapeutics go up and down completely randomly.

Pair Corralation between Dynavax Technologies and Allogene Therapeutics

Given the investment horizon of 90 days Dynavax Technologies is expected to generate 0.38 times more return on investment than Allogene Therapeutics. However, Dynavax Technologies is 2.61 times less risky than Allogene Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Allogene Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  1,348  in Dynavax Technologies on October 4, 2024 and sell it today you would lose (71.00) from holding Dynavax Technologies or give up 5.27% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	99.7%
Values	Daily Returns

Dynavax Technologies  vs.  Allogene Therapeutics

Dynavax Technologies

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Dynavax Technologies are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Dynavax Technologies showed solid returns over the last few months and may actually be approaching a breakup point.

Allogene Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Allogene Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Dynavax Technologies and Allogene Therapeutics

The main advantage of trading using opposite Dynavax Technologies and Allogene Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, Allogene Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allogene Therapeutics will offset losses from the drop in Allogene Therapeutics' long position.

The idea behind Dynavax Technologies and Allogene Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.